When compared with then-current phase 3 data investigating paclitaxel treatment alone in recurrent ovarian cancer, Optune plus paclitaxel almost doubled progression-free survival as well as ...

However, it is not known how often CJD-associated MRI changes are identified at the initial imaging report, whether the most sensitive sequences are used, and what impact MRI-diagnosis has on ...

Novocure has launched Optune, its first TTFields delivery ... containing the generator to receive continuous treatment without having to change his or her daily routine. For optimal outcomes ...